JP2012520469A - 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット - Google Patents

性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット Download PDF

Info

Publication number
JP2012520469A
JP2012520469A JP2011554259A JP2011554259A JP2012520469A JP 2012520469 A JP2012520469 A JP 2012520469A JP 2011554259 A JP2011554259 A JP 2011554259A JP 2011554259 A JP2011554259 A JP 2011554259A JP 2012520469 A JP2012520469 A JP 2012520469A
Authority
JP
Japan
Prior art keywords
biomarker
biomarkers
expression
subject
degree
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011554259A
Other languages
English (en)
Japanese (ja)
Inventor
ストリーパー，ロバート・ティー
イズビッカ，エルジュビェタ
ベック，サン・エイチ
Original Assignee
キャンサー・プリヴェンション・アンド・キュア，リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/403,369 external-priority patent/US8541183B2/en
Application filed by キャンサー・プリヴェンション・アンド・キュア，リミテッド filed Critical キャンサー・プリヴェンション・アンド・キュア，リミテッド
Publication of JP2012520469A publication Critical patent/JP2012520469A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011554259A 2009-03-12 2010-03-12 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット Pending JP2012520469A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/403,369 2009-03-12
US12/403,369 US8541183B2 (en) 2007-09-11 2009-03-12 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
US23719809P 2009-08-26 2009-08-26
US61/237,198 2009-08-26
PCT/US2010/027243 WO2010105235A2 (en) 2009-03-12 2010-03-12 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015151999A Division JP6250600B2 (ja) 2009-03-12 2015-07-31 非小細胞肺癌バイオマーカーを検出する方法

Publications (1)

Publication Number Publication Date
JP2012520469A true JP2012520469A (ja) 2012-09-06

Family

ID=42729154

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2011554259A Pending JP2012520469A (ja) 2009-03-12 2010-03-12 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2015151999A Active JP6250600B2 (ja) 2009-03-12 2015-07-31 非小細胞肺癌バイオマーカーを検出する方法
JP2017224257A Active JP6774925B2 (ja) 2009-03-12 2017-11-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット
JP2019081332A Pending JP2019158890A (ja) 2009-03-12 2019-04-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2021154089A Pending JP2022000650A (ja) 2009-03-12 2021-09-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2024003857A Withdrawn JP2024024128A (ja) 2009-03-12 2024-01-15 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2025078265A Pending JP2025114736A (ja) 2009-03-12 2025-05-08 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2015151999A Active JP6250600B2 (ja) 2009-03-12 2015-07-31 非小細胞肺癌バイオマーカーを検出する方法
JP2017224257A Active JP6774925B2 (ja) 2009-03-12 2017-11-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット
JP2019081332A Pending JP2019158890A (ja) 2009-03-12 2019-04-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2021154089A Pending JP2022000650A (ja) 2009-03-12 2021-09-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2024003857A Withdrawn JP2024024128A (ja) 2009-03-12 2024-01-15 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2025078265A Pending JP2025114736A (ja) 2009-03-12 2025-05-08 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット

Country Status (10)

Country Link
US (1) US11474104B2 (enExample)
EP (4) EP3444359A1 (enExample)
JP (7) JP2012520469A (enExample)
KR (2) KR101900016B1 (enExample)
CN (4) CN108181457B (enExample)
AU (3) AU2010223911A1 (enExample)
CA (2) CA3024643C (enExample)
ES (1) ES2703714T3 (enExample)
PL (1) PL3257953T3 (enExample)
WO (1) WO2010105235A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018528441A (ja) * 2015-09-11 2018-09-27 アプタマー サイエンス インコーポレイテッドＡｐｔａｍｅｒ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
AU2012249288C1 (en) * 2011-04-29 2017-12-21 Lung Cancer Proteomics Llc Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
WO2017044715A1 (en) * 2015-09-09 2017-03-16 Somalogic, Inc. Methods for developing personalized drug treatment plans and targeted drug development based on proteomic profiles
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN112501140B (zh) * 2020-12-16 2022-03-18 熊猫乳品集团股份有限公司 一种生物活性多肽yfgsgfaapffivrhqllkk及其制备方法和应用
TWI796010B (zh) * 2021-11-23 2023-03-11 國立高雄大學 基質金屬蛋白酶-1胜肽拓印導電聚合物及其用途
CN117907508A (zh) * 2023-12-19 2024-04-19 查理高特(青岛)健康科技有限公司 基于代谢组学的高尿酸血症及尿酸性肾病的风险预测系统

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002542485A (ja) * 1999-04-20 2002-12-10 オイ メディックス バイオケミカ エービー 気道炎症の存在及び重症度を評価するための方法及びテストキット
JP2004526154A (ja) * 2001-03-12 2004-08-26 モノジェン インコーポレイテッド 細胞ベースの検出および病態の判別
US20060084126A1 (en) * 2004-10-20 2006-04-20 Onco Detectors International, Llc Migration inhibitory factor in serum as a tumor marker for prostate, bladder, breast, ovarian, kidney and lung cancer
WO2006045318A2 (en) * 2004-10-27 2006-05-04 Aarhus Universitet Diagnosis and treatment of immune-related diseases
WO2008063413A2 (en) * 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69837529T2 (de) 1997-02-12 2007-07-26 Electrophoretics Ltd., Cobham Proteinmarker für lungenkrebs und deren verwendung
US20070092917A1 (en) 1998-05-01 2007-04-26 Isabelle Guyon Biomarkers for screening, predicting, and monitoring prostate disease
RU2236251C2 (ru) 1999-02-12 2004-09-20 Дзе Скриппс Рисерч Инститьют Способы лечения опухолей и метастазов с использованием комбинации антиангиогенной терапии и иммунотерапии
EP1157041B1 (en) 1999-03-01 2005-06-01 Genentech, Inc. Antibodies for cancer therapy and diagnosis
CA2371385A1 (en) * 1999-04-26 2000-11-02 Surromed, Inc. Phenotype and biological marker identification system
EP1299530A4 (en) * 2000-07-12 2005-03-09 Smithkline Beecham Corp NEW COMPOUNDS
US20030190602A1 (en) 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
EP1801240A1 (en) 2001-06-05 2007-06-27 Auckland Uniservices Limited Methods and compositions for assessment of pulmonary function and disorders
US20030134339A1 (en) 2002-01-14 2003-07-17 Thomas Brown Proteomics based method for toxicology testing
JP2005522228A (ja) 2002-04-11 2005-07-28 オックスフォード グライコサイエンシス （ユーケイ） リミテッド 癌に関与するタンパク質
US20060088894A1 (en) 2002-05-10 2006-04-27 Eastern Virginia Medical School Prostate cancer biomarkers
AU2003240495A1 (en) * 2002-06-04 2003-12-19 Incyte Corporation Diagnostics markers for lung cancer
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
CN1854313B (zh) * 2002-09-30 2010-10-20 肿瘤疗法科学股份有限公司 非小细胞肺癌的诊断方法
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
CA2515929C (en) * 2003-02-14 2013-11-19 Children's Hospital & Research Center At Oakland Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions
AU2004253846A1 (en) * 2003-03-04 2005-01-13 Wyeth Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
CN1795187A (zh) * 2003-03-27 2006-06-28 兰肯瑙医学研究所 新型ido抑制剂及其使用方法
JP2005044330A (ja) 2003-07-24 2005-02-17 Univ Of California San Diego 弱仮説生成装置及び方法、学習装置及び方法、検出装置及び方法、表情学習装置及び方法、表情認識装置及び方法、並びにロボット装置
JP4938451B2 (ja) 2004-03-23 2012-05-23 オンコセラピー・サイエンス株式会社 非小細胞肺癌の診断のための方法
AU2005231101A1 (en) 2004-03-30 2005-10-20 Eastern Virginia Medical School Lung cancer biomarkers
US20060154276A1 (en) 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
BRPI0518734A2 (pt) 2004-11-30 2008-12-02 Veridex Llc prognàstico de cÂncer de pulmço
CN1300580C (zh) 2004-12-31 2007-02-14 中国人民解放军第306医院 检测肝癌血清特征蛋白的质谱模型及其制备方法和应用
GB0508863D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Peptide
WO2006124451A2 (en) * 2005-05-11 2006-11-23 Centocor, Inc. Anti-il-13 antibodies, compositions, methods and uses
US20070099239A1 (en) 2005-06-24 2007-05-03 Raymond Tabibiazar Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
US8053183B2 (en) 2005-07-27 2011-11-08 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
TWI323734B (en) * 2005-08-19 2010-04-21 Abbott Lab Dual variable domain immunoglobulin and uses thereof
US7612181B2 (en) * 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
JPWO2007026773A1 (ja) 2005-08-31 2009-03-12 学校法人 久留米大学 医用診断処理装置
EP2269724A1 (de) 2005-10-29 2011-01-05 Bayer Technology Services GmbH Verfahren zur Bestimmung eines oder mehrerer Analyten in komplex zusammengesetzten Proben biologischen Ursprungs und dessen Verwendung
US20080133141A1 (en) 2005-12-22 2008-06-05 Frost Stephen J Weighted Scoring Methods and Use Thereof in Screening
US9347945B2 (en) 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
KR100760518B1 (ko) 2006-07-18 2007-09-20 삼성정밀공업 주식회사 가구용 도어의 닫힘 충격 완충 장치
US7840505B2 (en) 2006-11-02 2010-11-23 George Mason Intellectual Properties, Inc. Classification tool
WO2008077022A2 (en) * 2006-12-18 2008-06-26 The Johns Hopkins University Himf and btk in pulmonary, cardiac, and inflammation disorders
JP5085927B2 (ja) 2006-12-21 2012-11-28 ウィンテックポリマー株式会社 難燃性樹脂組成物
EP2139919A2 (en) * 2007-02-28 2010-01-06 Novimmune Sa Human anti-ip-10 antibodies and uses thereof
AU2008236634A1 (en) 2007-04-05 2008-10-16 Aureon Laboratories, Inc. Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
EP2515116A1 (en) 2007-05-18 2012-10-24 Duke University Serum biomarkers for the early detection of lung cancer
EP2156187A4 (en) 2007-06-15 2010-07-21 Biosite Inc METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND / OR PROGNOSIS OF OVARY CANCER AND LUNG CANCER
US7888051B2 (en) * 2007-09-11 2011-02-15 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
US8541183B2 (en) * 2007-09-11 2013-09-24 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
US20090069189A1 (en) 2007-09-11 2009-03-12 Cancer Prevention And Cure, Ltd. Method of identifying proteins in human serum indicative of pathologies of human lung tissues
JP5159242B2 (ja) 2007-10-18 2013-03-06 キヤノン株式会社 診断支援装置、診断支援装置の制御方法、およびそのプログラム
WO2009074276A2 (en) 2007-12-10 2009-06-18 Roche Diagnostics Gmbh Marker panel for colorectal cancer
CA2878025C (en) 2008-01-18 2018-12-11 President And Fellows Of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
EP2329260A4 (en) 2008-03-04 2011-08-03 Ridge Diagnostics Inc DIAGNOSIS AND MONITORING OF DEPRESSIVE DISORDERS BASED ON A PLURALITY OF BIOMARKER PANELS
CN101587125B (zh) 2008-05-21 2013-07-24 林标扬 高表达癌症标记物和低表达组织器官标记物组合试剂盒
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CA3011730C (en) 2008-09-09 2022-05-17 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CN101988059B (zh) 2009-07-30 2014-04-02 江苏命码生物科技有限公司 胃癌检测标记物及其检测试剂盒和生物芯片
CN103582815A (zh) 2011-02-24 2014-02-12 佛米利昂公司 用于卵巢癌的生物标志物组、诊断方法和测试试剂盒
AU2012249288C1 (en) 2011-04-29 2017-12-21 Lung Cancer Proteomics Llc Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
WO2015066564A1 (en) 2013-10-31 2015-05-07 Cancer Prevention And Cure, Ltd. Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
WO2015138769A1 (en) 2014-03-12 2015-09-17 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for assessing patients with non-small cell lung cancer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002542485A (ja) * 1999-04-20 2002-12-10 オイ メディックス バイオケミカ エービー 気道炎症の存在及び重症度を評価するための方法及びテストキット
JP2004526154A (ja) * 2001-03-12 2004-08-26 モノジェン インコーポレイテッド 細胞ベースの検出および病態の判別
US20060084126A1 (en) * 2004-10-20 2006-04-20 Onco Detectors International, Llc Migration inhibitory factor in serum as a tumor marker for prostate, bladder, breast, ovarian, kidney and lung cancer
WO2006045318A2 (en) * 2004-10-27 2006-05-04 Aarhus Universitet Diagnosis and treatment of immune-related diseases
WO2008063413A2 (en) * 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
IIZASA T. ET AL.: "Elevated Levels of Circulating Plasma Matrix Metalloproteinase 9 in Non-Small Cell Lung Cancer Patie", CLINICAL CANCER RESEARCH, vol. 5, no. 1, JPN6013064606, January 1999 (1999-01-01), pages 149 - 153, XP002405022, ISSN: 0002718473 *
K. IZUHARA ET AL.: "IL-13: A Promising Therapeutic Target for Bronchial Asthma", CURRENT MEDICINAL CHEMISTRY, vol. 13, no. 19, JPN6013064604, 1 January 2006 (2006-01-01), pages 2291 - 2298, XP055013485, ISSN: 0002718472, DOI: 10.2174/092986706777935140 *
WILLS-KARP MARSHA ETAL.: "Interleukin-13 in asthma", CURRENT OPINION IN PLUMONARY MEDICINE, vol. 9, no. 1, JPN6013064609, 1 January 2003 (2003-01-01), US, pages 21 - 27, XP009139299, ISSN: 0002718474, DOI: 10.1097/00063198-200301000-00004 *
吉川衛ほか: "喘息を合併した副鼻腔炎患者由来繊維芽細胞におけるIP-10およびI-TACの発現について", 日本鼻化学会会誌, vol. 46, no. 3, JPN6015003500, 31 August 2007 (2007-08-31), pages 237, ISSN: 0002995665 *
尾長谷靖ほか: "気管支ぜん喘息におけるマトリックスメタロプロテアーゼファミリーの役割", 最新医学, vol. 61, no. 3, JPN6015003505, 10 March 2006 (2006-03-10), pages 485 - 490, ISSN: 0002995667 *
烏帽子田彰、中村裕之: "気管支喘息症の重症度に関連する好酸球関連蛋白の機能とその遺伝子多型", 気管支喘息難治・重傷化の病因・病態の解明に関する研究 平成19年度 総括・分担研究報告書, JPN6015003502, 2008, pages 48 - 51, ISSN: 0002995666 *
笠山宗正ほか: "喘息患者における高感度ＣＲＰ測定の意義", 月刊アレルギーの臨床, JPN6015003506, 20 August 2005 (2005-08-20), pages 757 - 759, ISSN: 0002995668 *
高橋尚人ほか: "サイトカインプロファイルによる慢性肺疾患児の多種類持続的高サイトカイン血症の証明", 日本小児科学会雑誌, vol. 113, no. 2, JPN6015003497, 1 February 2009 (2009-02-01), pages 246, ISSN: 0002995671 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018528441A (ja) * 2015-09-11 2018-09-27 アプタマー サイエンス インコーポレイテッドＡｐｔａｍｅｒ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法

Also Published As

Publication number Publication date
KR102061441B1 (ko) 2019-12-31
KR20120010229A (ko) 2012-02-02
JP6250600B2 (ja) 2017-12-20
AU2016228188A1 (en) 2016-09-29
JP2025114736A (ja) 2025-08-05
EP2406401A4 (en) 2013-01-09
US11474104B2 (en) 2022-10-18
JP2018072348A (ja) 2018-05-10
CA3024643A1 (en) 2010-09-16
JP2024024128A (ja) 2024-02-21
EP3257953A1 (en) 2017-12-20
CN104535765A (zh) 2015-04-22
CN113189342B (zh) 2024-12-03
EP2857522A3 (en) 2015-10-14
AU2018202110A1 (en) 2018-04-19
JP2016006426A (ja) 2016-01-14
EP3444359A1 (en) 2019-02-20
CA3024643C (en) 2021-08-03
KR20180104190A (ko) 2018-09-19
AU2010223911A1 (en) 2011-10-06
CN102405296A (zh) 2012-04-04
PL3257953T3 (pl) 2019-05-31
CN113189342A (zh) 2021-07-30
ES2703714T3 (es) 2019-03-12
EP2857522A2 (en) 2015-04-08
CA2755301A1 (en) 2010-09-16
AU2018202110B2 (en) 2020-09-03
EP2406401A2 (en) 2012-01-18
JP2022000650A (ja) 2022-01-04
JP6774925B2 (ja) 2020-10-28
WO2010105235A2 (en) 2010-09-16
AU2016228188B2 (en) 2018-01-04
EP3257953B1 (en) 2018-09-26
CA2755301C (en) 2019-01-08
CN108181457A (zh) 2018-06-19
WO2010105235A3 (en) 2011-02-24
JP2019158890A (ja) 2019-09-19
KR101900016B1 (ko) 2018-09-20
CN108181457B (zh) 2021-03-30
US20180356423A1 (en) 2018-12-13

Similar Documents

Publication Publication Date Title
JP6774925B2 (ja) 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット
US9933429B2 (en) Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
EP2781913B1 (en) Method for aiding in the diagnosis and therapy of asthma and lung cancer
CN101646942A (zh) 载脂蛋白指纹图谱技术
JP2018504609A (ja) 膵癌のバイオマーカー
JP2018529931A (ja) 喀痰試料中のバイオマーカーとしての細胞外遊離ヌクレオソームの使用
US8053198B2 (en) Diagnostic methods
JP2012526543A5 (enExample)
Han et al. Development and validation of a decision tree classification model for the essential hypertension based on serum protein biomarkers
HK40058647A (en) Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130312

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20131218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140107

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140404

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140411

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140707

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150430

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150525

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151109